Treatment of Dacryocystitis Caused by Fungi

Clinical scenario

Fungal organisms are an uncommon but recognised cause of dacryocystitis, reported in approximately 4% to 7% of cases. The most commonly isolated genus is Candida, though Aspergillus and Mucor may also be identified. Confirming a fungal aetiology — for example through culture — defines a distinct management pathway from bacterial dacryocystitis.

Management combines systemic antifungal therapy — with both oral and intravenous options available depending on severity — alongside topical antifungal eyedrops applied directly to the affected eye.

The complete structured regimen, including agent selection criteria, route, and sequencing, is available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1007/s11908-012-0238-8

As for fungi, they have been reported to be present in 4% to 7% of cases, the most commonly isolated genus being Candida, although Aspergillus and Mucor may also be found.
Itraconazole 200 mg/24 h oral or Fluconazole 200 mg/12 h oral
Amphotericin B 60 mg/24 h iv or Itraconazole 100 mg/24 h iv
Amphotericin B 0.1% 1/4 h or Fluconazole (0.2%) 1/4 h

View source ↗